Eintrag weiter verarbeiten
Blockade of HMGB1 signaling pathway by ethyl pyruvate inhibits tumor growth in diffuse large B-cell lymphoma
Gespeichert in:
Zeitschriftentitel: | Cell Death & Disease |
---|---|
Personen und Körperschaften: | , , , , |
In: | Cell Death & Disease, 10, 2019, 5 |
Format: | E-Article |
Sprache: | Englisch |
veröffentlicht: |
Springer Science and Business Media LLC
|
Schlagwörter: |
author_facet |
Zhang, Tian Guan, Xu-Wen Gribben, John G. Liu, Feng-Ting Jia, Li Zhang, Tian Guan, Xu-Wen Gribben, John G. Liu, Feng-Ting Jia, Li |
---|---|
author |
Zhang, Tian Guan, Xu-Wen Gribben, John G. Liu, Feng-Ting Jia, Li |
spellingShingle |
Zhang, Tian Guan, Xu-Wen Gribben, John G. Liu, Feng-Ting Jia, Li Cell Death & Disease Blockade of HMGB1 signaling pathway by ethyl pyruvate inhibits tumor growth in diffuse large B-cell lymphoma Cancer Research Cell Biology Cellular and Molecular Neuroscience Immunology |
author_sort |
zhang, tian |
spelling |
Zhang, Tian Guan, Xu-Wen Gribben, John G. Liu, Feng-Ting Jia, Li 2041-4889 Springer Science and Business Media LLC Cancer Research Cell Biology Cellular and Molecular Neuroscience Immunology http://dx.doi.org/10.1038/s41419-019-1563-8 <jats:title>Abstract</jats:title><jats:p>High mobility group box 1 (HMGB1) protein in the tumor microenvironment actively contributes to tumor progression but its role in diffuse large B-cell lymphoma (DLBCL) is unknown. The aim of this study was to determine the mechanism by which HMGB1 promotes tumor growth in DLBCL and whether blockade of HMGB1 signaling pathway could inhibit tumorigenesis. We report that HMGB1 promotes proliferation of DLBCL cells by activation of AKT, extracellular signal-regulated kinases 1/2 (ERK1/2), signal transducer and activator of transcription 3 (STAT3) and SRC Proto-Oncogene, Non-Receptor Tyrosine Kinase (Src). Ethyl pyruvate (EP), an anti-inflammatory agent, inhibits HMGB1 active release from DLBCL cells and significantly inhibited proliferation of DLBCL cells in vitro. Treatment with EP significantly prevented and inhibited tumor growth in vivo and prolonged DLBCL-bearing mice survival. EP significantly downregulated HMGB1 expression and phosphorylation of Src and ERK1/2 in mice lymphoma tissue. EP induced accumulation of the cell cycle inhibitor p27 but downregulated expression of cyclin-dependent kinase 2 (CDK2). Increased nuclear translocation of p27 interacted with CDK2 and cyclin A, which led to blockade of cell cycle progression at the G1 to S phase transition. In conclusion, we demonstrated for the first time that blockade of HMGB1-mediated signaling pathway by EP effectively inhibited DLBCL tumorigenesis and disease progression.</jats:p> Blockade of HMGB1 signaling pathway by ethyl pyruvate inhibits tumor growth in diffuse large B-cell lymphoma Cell Death & Disease |
doi_str_mv |
10.1038/s41419-019-1563-8 |
facet_avail |
Online Free |
finc_class_facet |
Biologie Psychologie Medizin |
format |
ElectronicArticle |
fullrecord |
blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTAzOC9zNDE0MTktMDE5LTE1NjMtOA |
id |
ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTAzOC9zNDE0MTktMDE5LTE1NjMtOA |
institution |
DE-Bn3 DE-Brt1 DE-Zwi2 DE-D161 DE-Gla1 DE-Zi4 DE-15 DE-Pl11 DE-Rs1 DE-105 DE-14 DE-Ch1 DE-L229 DE-D275 |
imprint |
Springer Science and Business Media LLC, 2019 |
imprint_str_mv |
Springer Science and Business Media LLC, 2019 |
issn |
2041-4889 |
issn_str_mv |
2041-4889 |
language |
English |
mega_collection |
Springer Science and Business Media LLC (CrossRef) |
match_str |
zhang2019blockadeofhmgb1signalingpathwaybyethylpyruvateinhibitstumorgrowthindiffuselargebcelllymphoma |
publishDateSort |
2019 |
publisher |
Springer Science and Business Media LLC |
recordtype |
ai |
record_format |
ai |
series |
Cell Death & Disease |
source_id |
49 |
title |
Blockade of HMGB1 signaling pathway by ethyl pyruvate inhibits tumor growth in diffuse large B-cell lymphoma |
title_unstemmed |
Blockade of HMGB1 signaling pathway by ethyl pyruvate inhibits tumor growth in diffuse large B-cell lymphoma |
title_full |
Blockade of HMGB1 signaling pathway by ethyl pyruvate inhibits tumor growth in diffuse large B-cell lymphoma |
title_fullStr |
Blockade of HMGB1 signaling pathway by ethyl pyruvate inhibits tumor growth in diffuse large B-cell lymphoma |
title_full_unstemmed |
Blockade of HMGB1 signaling pathway by ethyl pyruvate inhibits tumor growth in diffuse large B-cell lymphoma |
title_short |
Blockade of HMGB1 signaling pathway by ethyl pyruvate inhibits tumor growth in diffuse large B-cell lymphoma |
title_sort |
blockade of hmgb1 signaling pathway by ethyl pyruvate inhibits tumor growth in diffuse large b-cell lymphoma |
topic |
Cancer Research Cell Biology Cellular and Molecular Neuroscience Immunology |
url |
http://dx.doi.org/10.1038/s41419-019-1563-8 |
publishDate |
2019 |
physical |
|
description |
<jats:title>Abstract</jats:title><jats:p>High mobility group box 1 (HMGB1) protein in the tumor microenvironment actively contributes to tumor progression but its role in diffuse large B-cell lymphoma (DLBCL) is unknown. The aim of this study was to determine the mechanism by which HMGB1 promotes tumor growth in DLBCL and whether blockade of HMGB1 signaling pathway could inhibit tumorigenesis. We report that HMGB1 promotes proliferation of DLBCL cells by activation of AKT, extracellular signal-regulated kinases 1/2 (ERK1/2), signal transducer and activator of transcription 3 (STAT3) and SRC Proto-Oncogene, Non-Receptor Tyrosine Kinase (Src). Ethyl pyruvate (EP), an anti-inflammatory agent, inhibits HMGB1 active release from DLBCL cells and significantly inhibited proliferation of DLBCL cells in vitro. Treatment with EP significantly prevented and inhibited tumor growth in vivo and prolonged DLBCL-bearing mice survival. EP significantly downregulated HMGB1 expression and phosphorylation of Src and ERK1/2 in mice lymphoma tissue. EP induced accumulation of the cell cycle inhibitor p27 but downregulated expression of cyclin-dependent kinase 2 (CDK2). Increased nuclear translocation of p27 interacted with CDK2 and cyclin A, which led to blockade of cell cycle progression at the G1 to S phase transition. In conclusion, we demonstrated for the first time that blockade of HMGB1-mediated signaling pathway by EP effectively inhibited DLBCL tumorigenesis and disease progression.</jats:p> |
container_issue |
5 |
container_start_page |
0 |
container_title |
Cell Death & Disease |
container_volume |
10 |
format_de105 |
Article, E-Article |
format_de14 |
Article, E-Article |
format_de15 |
Article, E-Article |
format_de520 |
Article, E-Article |
format_de540 |
Article, E-Article |
format_dech1 |
Article, E-Article |
format_ded117 |
Article, E-Article |
format_degla1 |
E-Article |
format_del152 |
Buch |
format_del189 |
Article, E-Article |
format_dezi4 |
Article |
format_dezwi2 |
Article, E-Article |
format_finc |
Article, E-Article |
format_nrw |
Article, E-Article |
_version_ |
1792334309755977734 |
geogr_code |
not assigned |
last_indexed |
2024-03-01T14:26:37.06Z |
geogr_code_person |
not assigned |
openURL |
url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Blockade+of+HMGB1+signaling+pathway+by+ethyl+pyruvate+inhibits+tumor+growth+in+diffuse+large+B-cell+lymphoma&rft.date=2019-04-15&genre=article&issn=2041-4889&volume=10&issue=5&jtitle=Cell+Death+%26+Disease&atitle=Blockade+of+HMGB1+signaling+pathway+by+ethyl+pyruvate+inhibits+tumor+growth+in+diffuse+large+B-cell+lymphoma&aulast=Jia&aufirst=Li&rft_id=info%3Adoi%2F10.1038%2Fs41419-019-1563-8&rft.language%5B0%5D=eng |
SOLR | |
_version_ | 1792334309755977734 |
author | Zhang, Tian, Guan, Xu-Wen, Gribben, John G., Liu, Feng-Ting, Jia, Li |
author_facet | Zhang, Tian, Guan, Xu-Wen, Gribben, John G., Liu, Feng-Ting, Jia, Li, Zhang, Tian, Guan, Xu-Wen, Gribben, John G., Liu, Feng-Ting, Jia, Li |
author_sort | zhang, tian |
container_issue | 5 |
container_start_page | 0 |
container_title | Cell Death & Disease |
container_volume | 10 |
description | <jats:title>Abstract</jats:title><jats:p>High mobility group box 1 (HMGB1) protein in the tumor microenvironment actively contributes to tumor progression but its role in diffuse large B-cell lymphoma (DLBCL) is unknown. The aim of this study was to determine the mechanism by which HMGB1 promotes tumor growth in DLBCL and whether blockade of HMGB1 signaling pathway could inhibit tumorigenesis. We report that HMGB1 promotes proliferation of DLBCL cells by activation of AKT, extracellular signal-regulated kinases 1/2 (ERK1/2), signal transducer and activator of transcription 3 (STAT3) and SRC Proto-Oncogene, Non-Receptor Tyrosine Kinase (Src). Ethyl pyruvate (EP), an anti-inflammatory agent, inhibits HMGB1 active release from DLBCL cells and significantly inhibited proliferation of DLBCL cells in vitro. Treatment with EP significantly prevented and inhibited tumor growth in vivo and prolonged DLBCL-bearing mice survival. EP significantly downregulated HMGB1 expression and phosphorylation of Src and ERK1/2 in mice lymphoma tissue. EP induced accumulation of the cell cycle inhibitor p27 but downregulated expression of cyclin-dependent kinase 2 (CDK2). Increased nuclear translocation of p27 interacted with CDK2 and cyclin A, which led to blockade of cell cycle progression at the G1 to S phase transition. In conclusion, we demonstrated for the first time that blockade of HMGB1-mediated signaling pathway by EP effectively inhibited DLBCL tumorigenesis and disease progression.</jats:p> |
doi_str_mv | 10.1038/s41419-019-1563-8 |
facet_avail | Online, Free |
finc_class_facet | Biologie, Psychologie, Medizin |
format | ElectronicArticle |
format_de105 | Article, E-Article |
format_de14 | Article, E-Article |
format_de15 | Article, E-Article |
format_de520 | Article, E-Article |
format_de540 | Article, E-Article |
format_dech1 | Article, E-Article |
format_ded117 | Article, E-Article |
format_degla1 | E-Article |
format_del152 | Buch |
format_del189 | Article, E-Article |
format_dezi4 | Article |
format_dezwi2 | Article, E-Article |
format_finc | Article, E-Article |
format_nrw | Article, E-Article |
geogr_code | not assigned |
geogr_code_person | not assigned |
id | ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTAzOC9zNDE0MTktMDE5LTE1NjMtOA |
imprint | Springer Science and Business Media LLC, 2019 |
imprint_str_mv | Springer Science and Business Media LLC, 2019 |
institution | DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161, DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229, DE-D275 |
issn | 2041-4889 |
issn_str_mv | 2041-4889 |
language | English |
last_indexed | 2024-03-01T14:26:37.06Z |
match_str | zhang2019blockadeofhmgb1signalingpathwaybyethylpyruvateinhibitstumorgrowthindiffuselargebcelllymphoma |
mega_collection | Springer Science and Business Media LLC (CrossRef) |
physical | |
publishDate | 2019 |
publishDateSort | 2019 |
publisher | Springer Science and Business Media LLC |
record_format | ai |
recordtype | ai |
series | Cell Death & Disease |
source_id | 49 |
spelling | Zhang, Tian Guan, Xu-Wen Gribben, John G. Liu, Feng-Ting Jia, Li 2041-4889 Springer Science and Business Media LLC Cancer Research Cell Biology Cellular and Molecular Neuroscience Immunology http://dx.doi.org/10.1038/s41419-019-1563-8 <jats:title>Abstract</jats:title><jats:p>High mobility group box 1 (HMGB1) protein in the tumor microenvironment actively contributes to tumor progression but its role in diffuse large B-cell lymphoma (DLBCL) is unknown. The aim of this study was to determine the mechanism by which HMGB1 promotes tumor growth in DLBCL and whether blockade of HMGB1 signaling pathway could inhibit tumorigenesis. We report that HMGB1 promotes proliferation of DLBCL cells by activation of AKT, extracellular signal-regulated kinases 1/2 (ERK1/2), signal transducer and activator of transcription 3 (STAT3) and SRC Proto-Oncogene, Non-Receptor Tyrosine Kinase (Src). Ethyl pyruvate (EP), an anti-inflammatory agent, inhibits HMGB1 active release from DLBCL cells and significantly inhibited proliferation of DLBCL cells in vitro. Treatment with EP significantly prevented and inhibited tumor growth in vivo and prolonged DLBCL-bearing mice survival. EP significantly downregulated HMGB1 expression and phosphorylation of Src and ERK1/2 in mice lymphoma tissue. EP induced accumulation of the cell cycle inhibitor p27 but downregulated expression of cyclin-dependent kinase 2 (CDK2). Increased nuclear translocation of p27 interacted with CDK2 and cyclin A, which led to blockade of cell cycle progression at the G1 to S phase transition. In conclusion, we demonstrated for the first time that blockade of HMGB1-mediated signaling pathway by EP effectively inhibited DLBCL tumorigenesis and disease progression.</jats:p> Blockade of HMGB1 signaling pathway by ethyl pyruvate inhibits tumor growth in diffuse large B-cell lymphoma Cell Death & Disease |
spellingShingle | Zhang, Tian, Guan, Xu-Wen, Gribben, John G., Liu, Feng-Ting, Jia, Li, Cell Death & Disease, Blockade of HMGB1 signaling pathway by ethyl pyruvate inhibits tumor growth in diffuse large B-cell lymphoma, Cancer Research, Cell Biology, Cellular and Molecular Neuroscience, Immunology |
title | Blockade of HMGB1 signaling pathway by ethyl pyruvate inhibits tumor growth in diffuse large B-cell lymphoma |
title_full | Blockade of HMGB1 signaling pathway by ethyl pyruvate inhibits tumor growth in diffuse large B-cell lymphoma |
title_fullStr | Blockade of HMGB1 signaling pathway by ethyl pyruvate inhibits tumor growth in diffuse large B-cell lymphoma |
title_full_unstemmed | Blockade of HMGB1 signaling pathway by ethyl pyruvate inhibits tumor growth in diffuse large B-cell lymphoma |
title_short | Blockade of HMGB1 signaling pathway by ethyl pyruvate inhibits tumor growth in diffuse large B-cell lymphoma |
title_sort | blockade of hmgb1 signaling pathway by ethyl pyruvate inhibits tumor growth in diffuse large b-cell lymphoma |
title_unstemmed | Blockade of HMGB1 signaling pathway by ethyl pyruvate inhibits tumor growth in diffuse large B-cell lymphoma |
topic | Cancer Research, Cell Biology, Cellular and Molecular Neuroscience, Immunology |
url | http://dx.doi.org/10.1038/s41419-019-1563-8 |